150 related articles for article (PubMed ID: 3300561)
1. [Antiemetic effects of combinations of metoclopramide, droperidol and dexamethasone for the prevention of cisplatin-induced gastro-intestinal toxicity: a randomized crossover trial].
Fujii M; Kiura K; Kamei H; Okabe K; Toki H
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2257-61. PubMed ID: 3300561
[TBL] [Abstract][Full Text] [Related]
2. [Randomized crossover trial of the antiemetic effects obtained with metoclopramide and droperidol versus those obtained with metoclopramide, droperidol and methylprednisolone in patients receiving cis-platinum chemotherapy].
Fujii M; Kiura K; Tamai M; Okabe K; Toki H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2562-7. PubMed ID: 3527070
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
4. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
[TBL] [Abstract][Full Text] [Related]
5. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
[TBL] [Abstract][Full Text] [Related]
6. [The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
Dozono H; Yasuda M; Yokoyama S; Takahashi S; Ochiai K; Tsuruoka M; Morimoto O; Sasaki H; Arihiro T; Terashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1968-72. PubMed ID: 3429979
[TBL] [Abstract][Full Text] [Related]
7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
9. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
[TBL] [Abstract][Full Text] [Related]
10. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
[TBL] [Abstract][Full Text] [Related]
11. [Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis].
Umehara H; Sawamura N; Takahashi S; Kusano H; Yokoyama S; Suemasu K
Gan To Kagaku Ryoho; 1986 May; 13(5):1996-8. PubMed ID: 3010886
[No Abstract] [Full Text] [Related]
12. [The effect of metoclopramide, dexamethasone and antihistamine in the prevention of PAC chemotherapy-induced emesis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Feb; 40(2):153-9. PubMed ID: 3361170
[TBL] [Abstract][Full Text] [Related]
13. [Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
Sawamura N; Funaki Y; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Yoshioka S; Sakurai M; Eguchi K
Gan To Kagaku Ryoho; 1985 Apr; 12(4):943-6. PubMed ID: 3885865
[TBL] [Abstract][Full Text] [Related]
14. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.
Tsavaris N; Kosmas CH; Vadiaka M; Kontos A; Katsorida M; Dimitrakopoulos A; Zerai A; Koufos CH
J Exp Clin Cancer Res; 2001 Mar; 20(1):29-34. PubMed ID: 11370826
[TBL] [Abstract][Full Text] [Related]
16. [Randomized cross-over study on the effects of methylprednisolone, metoclopramide and droperidol on the control of nausea and vomiting associated with cis-platinum chemotherapy].
Niijima T; Isurugi K; Akaza H; Kondo Y; Kawabe K; Fujita K; Koiso K; Yokoyama M; Kinoshita K; Aso Y
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2376-82. PubMed ID: 3729492
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
18. Effective control of cisplatin induced emesis by combination drug regimen.
Misra R; Agarwal N
Indian J Cancer; 1994 Mar; 31(1):19-22. PubMed ID: 8063331
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
20. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
